Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Biomarkers of disease activity in multiple sclerosis.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
24th Biennial Meeting ISN/ASN 2013
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Central fatigue in multiple sclerosis: a review of the literature.
Flupirtine in pain management: pharmacological properties and clinical use.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
The impact of multiple sclerosis relapse treatment on migration of effector T cells - Preliminary study.
Multiple sclerosis: association with HL-A3.
Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Long-term effectiveness of glatiramer acetate in clinical practice conditions.
Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.

Pages